Updates are available Correction dated 2026-02-19
Click to view Correction: https://doi.org/10.1186/s12910-025-01362-7
-
Authors
Dubé, Karine https://orcid.org/0000-0003-3458-1539
Kanazawa, John
Taylor, Jeff
Dee, Lynda
Jones, Nora
Roebuck, Christopher
Sylla, Laurie
Louella, Michael
Kosmyna, Jan
Kelly, David
Clanton, Orbit
Palm, David
Campbell, Danielle M.
Giwa Onaiwu, Morénike
Patel, Hursch
Ndukwe, Samuel
Henley, Laney
Johnson, Mallory O.
Saberi, Parya
Brown, Brandon
Sauceda, John A.
Sugarman, Jeremy
-
Funding
Funding for this research was provided by:
National Institute of Mental Health (R21MH118120)
National Institute of Mental Health (R21MH122280)
- License Information
-
More Information
Article History
Received: 9 December 2020
Accepted: 23 June 2021
First Online: 30 June 2021
Change Date: 8 January 2026
Change Type: Update
Change Details: The given and family name of the co-author Morénike Giwa Onaiwu was corrected.
Change Date: 19 February 2026
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12910-025-01362-7
Declarations
:
: Not applicable. This manuscript did not involve human participants, human data, or human tissue.
: Not applicable. This manuscript does not contain any individual person’s data not contained in the peer-reviewed literature.
: Jeremy Sugarman is a member of Merck KGaA’s Bioethics Advisory Panel and Stem Cell Research Oversight Committee; a member of IQVIA’s Ethics Advisory Panel; a member of Aspen Neurosciences Scientific Advisory Board; a member of a Merck Data Monitoring Committee; a consultant to Biogen; and a consultant to Portola Pharmaceuticals Inc. None of these activities are related to the material discussed in this manuscript. No other authors have outside interests to declare.
